Expansion of CD25-Negative Forkhead Box P3-Positive T Cells during HIV and Mycobacterium tuberculosis Infection

Tuberculosis (TB) and HIV alter the immune system, and coinfected (HIV-TB) individuals usually present deregulations of T-lymphocytic immune response. We previously observed an increased frequency of “unconventional” CD4+CD25−FoxP3+ Treg (uTreg) population during HIV-TB disease. Therefore, we aimed to explore the phenotype and function of uTreg and conventional CD4+CD25+FoxP3+ Treg subsets (cTreg) in this context. We evaluated the expression of CD39, programmed cell death protein 1 (PD1), glucocorticoid-induced tumor necrosis factor receptor (GITR), and the effector/memory distribution by flow cytometry in cTreg and uTreg. Also, IL-10, TGF-β, IFN-γ production, and the suppressor capacity of uTregs were analyzed in cocultures with effector lymphocytes and compared with the effect of regulatory T cells (Tregs). We found diminished expression of CD39 and higher levels of PD1 on uTreg compared to cTreg in both HIV-TB and healthy donors (HD). In addition, uTreg and cTreg showed differences in maturation status in both HIV-TB and HD groups, due to the expansion of effector memory uTregs. Interestingly, both HIV-TB and HD showed a pronounced production of IFN-γ in uTreg population, though no significant differences were observed for IL-10 and TGF-β production between uTreg and cTreg. Moreover, IFN-γ+ cells were restricted to the CD39− uTreg population. Finally, when the suppressor capacity was evaluated, both uTreg and cTreg inhibited polyclonal T cell-proliferation and IFN-γ production in a similar extent. These findings suggest that uTregs, which are expanded during HIV-TB coinfection, exert regulatory functions in a similar way to cTregs despite an altered surface expression of Treg characteristic markers and differences in cytokine production.

[1]  Sing Sing Way,et al.  Regulatory T cell memory , 2015, Nature Reviews Immunology.

[2]  Chang H. Kim,et al.  Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted , 2015, The Journal of Immunology.

[3]  H. Salomón,et al.  HIV–TB coinfection impairs CD8+ T‐cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses , 2015, European journal of immunology.

[4]  A. Adegnika,et al.  CD4+CD25hiFOXP3+ Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel , 2015, PLoS neglected tropical diseases.

[5]  Lieping Chen,et al.  PD-1 Upregulated on Regulatory T Cells during Chronic Virus Infection Enhances the Suppression of CD8+ T Cell Immune Response via the Interaction with PD-L1 Expressed on CD8+ T Cells , 2015, The Journal of Immunology.

[6]  H. Salomón,et al.  Early Skewed Distribution of Total and HIV-Specific CD8+ T-Cell Memory Phenotypes during Primary HIV Infection Is Related to Reduced Antiviral Activity and Faster Disease Progression , 2014, PloS one.

[7]  J. Routy,et al.  Programmed Death-1 Is a Marker for Abnormal Distribution of Naive/Memory T Cell Subsets in HIV-1 Infection , 2013, The Journal of Immunology.

[8]  J. Maciejewski,et al.  Expansion of Effector Memory Regulatory T Cells Represents a Novel Prognostic Factor in Lower Risk Myelodysplastic Syndrome , 2012, The Journal of Immunology.

[9]  A. Ganser,et al.  IFN-γ Production by Allogeneic Foxp3+ Regulatory T Cells Is Essential for Preventing Experimental Graft-versus-Host Disease , 2012, The Journal of Immunology.

[10]  Antonio Lanzavecchia,et al.  Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. , 2012, Blood.

[11]  H. Salomón,et al.  Dynamics of Adrenal Steroids Are Related to Variations in Th1 and Treg Populations during Mycobacterium tuberculosis Infection in HIV Positive Persons , 2012, PloS one.

[12]  S. Kaveri,et al.  Mycobacterium tuberculosis promotes regulatory T-cell expansion via induction of programmed death-1 ligand 1 (PD-L1, CD274) on dendritic cells. , 2012, The Journal of infectious diseases.

[13]  Markus Sköld,et al.  Tuberculosis and HIV Co-Infection , 2012, PLoS pathogens.

[14]  P. Krammer,et al.  Molecular Mechanisms of Treg-Mediated T Cell Suppression , 2012, Front. Immun..

[15]  B. Levine,et al.  The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells , 2011, Science Translational Medicine.

[16]  Xiangmei Chen,et al.  Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients , 2011, Virology Journal.

[17]  C. Baecher-Allan,et al.  Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease , 2011, Nature Medicine.

[18]  K. Dheda,et al.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. , 2011, American journal of respiratory and critical care medicine.

[19]  Mario Roederer,et al.  SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[20]  C. Gray,et al.  FOXP3 Expression Is Upregulated in CD4+T Cells in Progressive HIV-1 Infection and Is a Marker of Disease Severity , 2010, PloS one.

[21]  M. Rojas,et al.  Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. , 2010, Tuberculosis.

[22]  N. Tubridy,et al.  CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis1 , 2009, The Journal of Immunology.

[23]  Wei He,et al.  Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells? , 2009, Arthritis research & therapy.

[24]  S. Sakaguchi,et al.  Regulatory T cells: how do they suppress immune responses? , 2009, International immunology.

[25]  T. Nomura,et al.  Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. , 2009, Immunity.

[26]  R. Casetti,et al.  Characterization of regulatory T cells identified as CD4+CD25highCD39+ in patients with active tuberculosis , 2009, Clinical and experimental immunology.

[27]  J. Smolen,et al.  Phenotypic and Functional Analysis of CD4+CD25−Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus1 , 2009, The Journal of Immunology.

[28]  D. Sojka,et al.  Mechanisms of regulatory T‐cell suppression – a diverse arsenal for a moving target , 2008, Immunology.

[29]  A. la Sala,et al.  Hydrolysis of extracellular ATP and immune suppression: humans versus mice. , 2008, Blood.

[30]  C. Kuo,et al.  The quantitative analysis of peripheral blood FOXP3‐expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients , 2007, European journal of clinical investigation.

[31]  P. Rossini,et al.  Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. , 2007, Blood.

[32]  M. Roncarolo,et al.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. , 2007, International immunology.

[33]  A. Caton,et al.  Role of TCR specificity in CD4+CD25+ regulatory T‐cell selection , 2006, Immunological reviews.

[34]  E. Shevach,et al.  The GITR–GITRL interaction: co-stimulation or contrasuppression of regulatory activity? , 2006, Nature Reviews Immunology.

[35]  C. Akdis,et al.  Mechanisms of immune suppression by interleukin‐10 and transforming growth factor‐β: the role of T regulatory cells , 2006, Immunology.

[36]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2003 .

[37]  T. Burroughs The Role Of T Regulatory Cells In Allergy And Autoimmune Disease And Potential Therapeutic Options , 2017 .